Coronavirus: China approves use of Roche’s anti-inflammation drug Actemra in battle against COVID-19 complications

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

from Lifestyle News: Lifestyle News Today, Indian Lifestyle News, World Lifestyle News Today - The Financial Express
Read The Rest:financialexpress...